Suven Pharmaceuticals Statistics

Total Valuation

Suven Pharmaceuticals has a market cap or net worth of INR 303.03 billion. The enterprise value is 295.47 billion.

Market Cap	303.03B
Enterprise Value	295.47B

Important Dates

The next estimated earnings date is Thursday, November 7, 2024.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

Suven Pharmaceuticals has 254.56 million shares outstanding. The number of shares has increased by 0.05% in one year.

Shares Outstanding	254.56M
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	2.23%
Owned by Institutions (%)	24.27%
Float	95.81M

Valuation Ratios

The trailing PE ratio is 126.01 and the forward PE ratio is 81.53.

PE Ratio	126.01
Forward PE	81.53
PS Ratio	32.42
PB Ratio	14.78
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	122.88
EV / Sales	31.62
EV / EBITDA	92.61
EV / EBIT	111.12
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.03
Debt / EBITDA	0.20
Debt / FCF	n/a
Interest Coverage	36.98

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	8.48%
Revenue Per Employee	7.83M
Profits Per Employee	2.02M
Employee Count	1,193
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +110.42% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+110.42%
50-Day Moving Average	1,107.55
200-Day Moving Average	798.62
Relative Strength Index (RSI)	55.22
Average Volume (20 Days)	438,576

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Suven Pharmaceuticals had revenue of INR 9.34 billion and earned 2.40 billion in profits. Earnings per share was 9.45.

Revenue	9.34B
Gross Profit	5.27B
Operating Income	2.66B
Pretax Income	3.25B
Net Income	2.40B
EBITDA	3.19B
EBIT	2.66B
Earnings Per Share (EPS)	9.45

Full Income Statement

Balance Sheet

The company has 8.21 billion in cash and 649.96 million in debt, giving a net cash position of 7.56 billion or 29.70 per share.

Cash & Cash Equivalents	8.21B
Total Debt	649.96M
Net Cash	7.56B
Net Cash Per Share	29.70
Equity (Book Value)	20.51B
Book Value Per Share	80.56
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 56.41%, with operating and profit margins of 28.45% and 25.73%.

Gross Margin	56.41%
Operating Margin	28.45%
Pretax Margin	34.76%
Profit Margin	25.73%
EBITDA Margin	34.14%
EBIT Margin	28.45%
FCF Margin	n/a

Dividends & Yields

Suven Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.05%
Shareholder Yield	-0.05%
Earnings Yield	0.79%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on September 25, 2020. It was a forward split with a ratio of 2.

Last Split Date	Sep 25, 2020
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a